company background image
500660

GlaxoSmithKline Pharmaceuticals BSE:500660 Stock Report

Last Price

₹1.26k

Market Cap

₹214.0b

7D

-2.7%

1Y

-22.7%

Updated

26 Jan, 2023

Data

Company Financials +

GlaxoSmithKline Pharmaceuticals Limited

BSE:500660 Stock Report

Mkt Cap: ₹214.0b

500660 Stock Overview

GlaxoSmithKline Pharmaceuticals Limited, a healthcare company, researches, develops, manufactures, and sells pharmaceutical medicines and vaccines in India and internationally.

500660 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth3/6
Past Performance3/6
Financial Health6/6
Dividends3/6

My Notes

New

Notes are coming soon

GlaxoSmithKline Pharmaceuticals Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for GlaxoSmithKline Pharmaceuticals
Historical stock prices
Current Share Price₹1,262.95
52 Week High₹1,734.90
52 Week Low₹1,260.00
Beta0.17
1 Month Change-5.07%
3 Month Change-8.38%
1 Year Change-22.71%
3 Year Change-24.53%
5 Year Change3.13%
Change since IPO973.71%

Recent News & Updates

Recent updates

Shareholder Returns

500660IN PharmaceuticalsIN Market
7D-2.7%-2.0%-1.9%
1Y-22.7%-3.4%2.9%

Return vs Industry: 500660 underperformed the Indian Pharmaceuticals industry which returned -5.1% over the past year.

Return vs Market: 500660 underperformed the Indian Market which returned 1.9% over the past year.

Price Volatility

Is 500660's price volatile compared to industry and market?
500660 volatility
500660 Average Weekly Movement1.5%
Pharmaceuticals Industry Average Movement4.9%
Market Average Movement5.6%
10% most volatile stocks in IN Market8.9%
10% least volatile stocks in IN Market3.3%

Stable Share Price: 500660 is less volatile than 75% of Indian stocks over the past 3 months, typically moving +/- 2% a week.

Volatility Over Time: 500660's weekly volatility (2%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19243,840Bhushan Akshikarhttps://india-pharma.gsk.com

GlaxoSmithKline Pharmaceuticals Limited, a healthcare company, researches, develops, manufactures, and sells pharmaceutical medicines and vaccines in India and internationally. The company offers prescription and non-prescription drugs for anti-infective, respiratory, dermatology, nutrition, gastrointestinal, and rare diseases; and consumer healthcare products. It provides its product under the Augmentin, Calpol, Ceftum, Eltroxin, CCM, Neosporin, Betnovate, T-bact, Tenovate, Flutivate, Physiogel, Zimig, Cobadex CZS, Infanrix Hexa, Synflorix, Supacef, Havrix, Menveo, Boostrix, Fluarix Tetra, Varilrix, Nucala, and Trelegy Ellipta brands.

GlaxoSmithKline Pharmaceuticals Limited Fundamentals Summary

How do GlaxoSmithKline Pharmaceuticals's earnings and revenue compare to its market cap?
500660 fundamental statistics
Market Cap₹213.95b
Earnings (TTM)₹3.94b
Revenue (TTM)₹32.88b

54.3x

P/E Ratio

6.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
500660 income statement (TTM)
Revenue₹32.88b
Cost of Revenue₹13.46b
Gross Profit₹19.42b
Other Expenses₹15.48b
Earnings₹3.94b

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

Feb 07, 2023

Earnings per share (EPS)23.26
Gross Margin59.07%
Net Profit Margin11.98%
Debt/Equity Ratio0%

How did 500660 perform over the long term?

See historical performance and comparison

Dividends

2.4%

Current Dividend Yield

133%

Payout Ratio